Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among high-risk patients with mild to moderate COVID-19 - The Lancet Regional Health – Western Pacific
No hay comentarios:
Publicar un comentario